Pagnozzi Alex M, Pannek Kerstin, Boyd Roslyn N, van Eijk Liza, George Joanne M, Bora Samudragupta, Bradford DanaKai, Fahey Michael, Ditchfield Michael, Malhotra Atul, Colditz Paul B, Fripp Jurgen
The Australian e-Health Research Centre, CSIRO, Brisbane, Australia.
The University of Queensland, School of Electrical Engineering and Computer Science, Brisbane, Australia.
Neuroimage Rep. 2025 Apr 19;5(2):100262. doi: 10.1016/j.ynirp.2025.100262. eCollection 2025 Jun.
Brain Magnetic Resonance Imaging (MRI) of high-risk infants in the neonatal period (from 26 weeks postmenstrual age to Term Equivalent Age (TEA)) is increasingly being used for the detection of brain injuries, and the early prognostication of adverse outcomes such as Cerebral Palsy (CP). While most imaging is performed around TEA in clinical practice for infants born preterm (<37 weeks of gestation), this would often require families to return to hospital for imaging. In this work, we extract structural biomarkers from MRI acquired both before and at TEA in a cohort of very preterm infants from the PPREMO and PREBO studies (n = 100), to determine if either time-point, or both combined, are predictive of both Bayley Scales of Infant and Toddler Development - Third Edition (Bayley-III) and the Neuro-sensory Motor Developmental Assessment (NSMDA) at 2 years. Using multivariable regression, moderately strong and statistically significant associations were found between brain structure on both early and TEA MRIs with 2-year outcomes (r = 0.39-0.55 for early MRI, r = 0.37-0.49 for Term MRI, r = 0.37-0.56 for early and TEA MRI combined). Importantly, brain biomarkers associated with early childhood outcomes from MRIs were identified, including white and grey matter volumes, deep grey matter and cerebellar volumes, and gyrification and surface area across the whole cortex. Early MRI showed the best prognostic accuracy along with combining timepoints, indicating the potential clinical benefit of Early MRI in predicting adverse outcomes.
新生儿期(从孕龄26周至足月等效年龄(TEA))高危婴儿的脑磁共振成像(MRI)越来越多地用于检测脑损伤,以及对诸如脑瘫(CP)等不良后果进行早期预后评估。虽然在临床实践中,大多数成像检查是在早产(<37周妊娠)婴儿的足月等效年龄左右进行的,但这通常需要家庭返回医院进行成像检查。在这项研究中,我们从PPREMO和PREBO研究的一组极早产婴儿(n = 100)在足月等效年龄之前和足月等效年龄时获取的MRI中提取结构生物标志物,以确定这两个时间点中的任何一个,或两者结合,是否能预测婴儿和幼儿发展贝利量表第三版(Bayley-III)以及2岁时的神经感觉运动发育评估(NSMDA)。使用多变量回归分析,发现早期和足月等效年龄MRI上的脑结构与2年结局之间存在中等强度且具有统计学意义的关联(早期MRI的r = 0.39 - 0.55,足月MRI的r = 0.37 - 0.49,早期和足月等效年龄MRI联合的r = 0.37 - 0.56)。重要的是,确定了与MRI儿童早期结局相关的脑生物标志物,包括白质和灰质体积、深部灰质和小脑体积,以及整个皮质的脑回形成和表面积。早期MRI与结合两个时间点显示出最佳的预后准确性,表明早期MRI在预测不良结局方面具有潜在的临床益处。